SCHEMBL6964856

SCHEMBL6964856

C[C@H](O)C1CCCN1Cc1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4331460 0.95
SCHEMBL15723668 0.87
SCHEMBL13416615 0.87
Hydrochloric Acid SCHEMBL637409 0.86 ALDH1A1 (0.46) ALDH1A1
SCHEMBL3568495 0.85 ALDH1A1 (0.56) ALDH1A1
SCHEMBL13369056 0.85 ALDH1A1 (0.56) ALDH1A1
SCHEMBL21234105 0.84
SCHEMBL18853923 0.83 NR1H2 (0.49)
SCHEMBL11309797 0.83 KDM4E (0.47)
SCHEMBL27010141 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0912512-B1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 2003-04-02 EP disclosed
US-6265408-B1 PSYCHOLOGICAL DISORDERS; ANTIDEPRESSANT SMITHKLINE BEECHAM PLC (GB) 2001-07-24 US disclosed
EP-0912512-A1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1999-05-06 EP disclosed
WO-1997048681-A1 SULPHONAMIDE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS SMITHKLINE BEECHAM PLC (GB) 1997-12-24 WO disclosed